Fastest growing Top 10 pharmaceutical business in the U.S., Europe & Japan in 2012, 12 consecutive quarters of operational sales growth in the Pharmaceuticals segment• Current plans are for new products to account for nearly half of the total sales in the Pharmaceuticals segment by 2017, Continued commitment to addressing most serious global unmet medical needs to help transform the lives of patients, R&D strategy builds on strong internal research and external innovation, Late stage pipeline features potential breakthrough therapies that will help transform patient care and sustain future growth
